Untitled-2 Untitled-2 Untitled-2
Healthcare
For Life®
1315 Capital invests in exceptional healthcare teams and companies

1315 Capital is a private investment firm with over $500 million under management that provides expansion and growth capital to commercial-stage medical technology, healthcare service, and specialty therapeutic companies. We target markets where high-quality management teams can rapidly scale platform companies into large and important businesses that positively impact patients, physicians, and the broader healthcare system.

Investment
Leadership

The 1315 Capital investment team combines financial and business development expertise with deep industry knowledge to support the growth of our portfolio companies.

Learn More

OPERATING
TEAMS

1315 Capital employs a unique Operating Team model to navigate diligence, drive decisions, and achieve premium exits.

Learn More

Tangible
ENGAGEMENT

1315 Capital has a deep network that it leverages for management talent, advisors, deal sourcing, diligence, and boards roles.

Learn More

News & Events
Greenbrook TMS Reports Record Fourth Quarter and Year End 2019 Financial Results
March 10, 2020
Interpace Diagnostics Announces Contract with BCBS of Massachusetts
March 10, 2020
Colorescience Launches Seven New Products with Patented EnviroScreen® Technology
March 02, 2020
Portfolio

Provider of AI-enabled decision support technology for global life sciences sales and marketing teams.

Medical technology company providing hydrophilic coatings to medical device manufacturers.

Cost-containment service company providing hospitals with turn key liquidation of used equipment.

Special needs equipment and supply company that serves the pediatric and adult special needs population.

Cosmeceutical company providing natural, mineral-based approach to skin protection and skin health.

Dermatology company committed to delivering innovative prescription therapies to dermatologists.

Oncology diagnostics company that provides oncologists and pathologists with comprehensive testing solutions in hematology and solid tumor molecular profiling.

Multi-center services company providing transcranial magnetic stimulation to mental health patients.

Cost-containment service company focused on reprocessing single-use medical devices.

Bioinformatics company providing evidence-based, clinically beneficial molecular diagnostic tests and pathology services.

Specialty pharmaceutical company focused on nutraceutical and women’s health products.

Medical technology company offering ultrasonic surgical tools and advanced wound care products to healthcare providers.

Medical device company focused on the orthopedic oncology market.

Medical device company providing functional electrical stimulation to neurological rehabilitation patients.

Forensic genomics company providing next-generation sequencing equipment, solutions, and software.